Replies to post #473564 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

On the other hand when a respected organization, like AACR repeats the allegation, then I believe it should be up to either the company or the lead clinician to explain why the allegation is untrue.

AACR looked at the trial registry record and saw that this was a randomized trial with PFS being the primary endpoint.

That failed, and that is what they printed.

Do not put this on AACR for NWBO not making the legally required update to ct.gov years ago.